Viewing Study NCT07176832

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:26 PM
Ignite Modification Date: 2025-12-30 @ 10:39 AM
Study NCT ID: NCT07176832
Status: COMPLETED
Last Update Posted: 2025-09-16
First Post: 2025-08-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Bioavailability of Stiripentol After Single Oral Dose of Capsule vs Suspension in Healthy Subjects (STILIQ)
Sponsor: Biocodex
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Dravet Syndrome View
None Epilepsy View
None Childhood View
None Epileptic Encephalopathy View
None Pediatric Epilepsy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Stiripentol View
None Diacomit View
None Oral Suspension View
None Bioavailability View
None Pharmacokinetics View
None Antiepileptic Drug View
None Crossover Study View
None Healthy Volunteers View
None Pediatric Epilepsy View
None Dravet Syndrome Treatment View